Workup for Asymptomatic Mild Leukopenia in a 35-Year-Old African-American Male
For this asymptomatic 35-year-old African-American male with mild leukopenia (WBC 3.01 × 10³/µL) and preserved ANC (2.75 × 10³/µL), the most appropriate initial step is to obtain peripheral blood smear review and consider Duffy antigen (Fy) phenotyping before pursuing extensive hematologic workup.
Understanding the Clinical Context
Benign Ethnic Neutropenia in African Americans
This patient's presentation is highly consistent with Duffy-null associated neutrophil count (DANC), a benign condition affecting 25-50% of people of African ancestry 1. The key features here are:
- WBC of 3.01 × 10³/µL (mildly low)
- ANC of 2.75 × 10³/µL (actually above the neutropenia threshold of 1.5 × 10³/µL)
- Asymptomatic presentation
- African-American ethnicity
Recent evidence demonstrates that Duffy-null individuals have significantly lower baseline WBC and ANC values (median WBC 3.24 vs. 6.65 × 10³/µL in general population) despite completely benign clinical courses 2. In fact, 64.1% of neutropenia referrals at urban centers with diverse populations are ultimately diagnosed with DANC 1.
Recommended Stepwise Workup
Step 1: Immediate Basic Evaluation
Obtain the following without delay:
- Repeat CBC with manual differential to confirm the values and assess for other cytopenias 3, 4
- Peripheral blood smear review to evaluate cell morphology and exclude dysplasia, blasts, or abnormal cells 4
- Comprehensive metabolic panel to assess organ function
- Medication history focusing on drugs that can cause neutropenia (antibiotics, anticonvulsants, antithyroid medications, NSAIDs)
- Infection history including recent viral illnesses, HIV risk factors
Step 2: Ethnicity-Specific Testing
Given the patient's African-American ethnicity and preserved ANC >1.0 × 10³/µL:
- Order Duffy antigen (Fy) phenotyping through blood bank testing 5, 1
- This is cost-effective and definitive
- 97% of tested patients with suspected DANC are confirmed Fy(a-b-) positive 1
- Avoids unnecessary bone marrow biopsies and specialist referrals
Step 3: If Duffy Testing is Positive (Fy(a-b-))
No further workup is needed if:
- Patient remains asymptomatic
- No recurrent infections
- ANC remains >1.0 × 10³/µL
- No other cytopenias present
- Peripheral smear is normal
Document this as benign ethnic neutropenia and reassure the patient. The lower reference interval for Duffy-null individuals is WBC 2.43-7.05 × 10³/µL and ANC 1.01-4.34 × 10³/µL 2.
Step 4: If Duffy Testing is Negative or ANC <1.0 × 10³/µL
Proceed with expanded evaluation:
- Antinuclear antibody (ANA) and rheumatoid factor to screen for autoimmune disorders 4
- Vitamin B12 and folate levels to exclude nutritional deficiencies 3
- HIV testing if risk factors present
- Thyroid function tests (hypothyroidism can cause neutropenia)
- Liver and spleen imaging if hepatosplenomegaly suspected on exam
Step 5: Consider Bone Marrow Biopsy Only If:
Do NOT perform bone marrow biopsy in this patient unless:
- ANC drops to <1.0 × 10³/µL persistently 5
- Development of other cytopenias
- Abnormal peripheral smear showing dysplasia or blasts
- Recurrent infections develop
- Duffy testing is negative and no other cause identified
- Progressive decline in counts over serial measurements
The evidence clearly shows that hematologic disorders are rare in patients with mild neutropenia (ANC ≥1.0 × 10³/µL), particularly among Black patients 5. Only 23% of neutropenia referrals had clinically relevant hematologic outcomes, and only 6 of these had ANC ≥1.0 × 10³/µL 5.
Critical Pitfalls to Avoid
Over-Investigation in Benign Ethnic Neutropenia
The most common error is subjecting African-American patients with DANC to unnecessary and costly hematologic workups including bone marrow biopsies 5, 1. This occurs because:
- Standard reference ranges don't account for ethnic variation
- Many clinicians are unaware of DANC
- Institutional ANC lower limits vary widely (0.91-2.40 × 10³/µL) 5
Misapplication of Acute Leukemia Guidelines
The provided guidelines [6-6] address workup of acute leukemia, which is completely irrelevant to this asymptomatic patient with preserved counts and no blasts. These guidelines should be ignored in this clinical context—they apply only when acute leukemia is suspected based on symptoms, blast cells, or severe cytopenias.
Monitoring Strategy
If DANC is confirmed:
- No routine hematology follow-up needed
- Recheck CBC only if symptoms develop (fever, recurrent infections)
- Educate patient about benign nature to prevent future unnecessary workups
If other cause identified or Duffy-negative:
- Follow-up CBC in 4-6 weeks
- Monitor for progression or development of symptoms
- Consider hematology referral if ANC <1.0 × 10³/µL or declining trend
Cost Considerations
Implementing Duffy phenotyping as first-line testing in appropriate patients reduces healthcare costs significantly. Average laboratory visit costs for DANC patients are substantially lower than those requiring extensive workup ($363.82 vs. $737.93) 1, and prevents unnecessary specialist referrals in the majority of cases.